Obesity coverage by US payors should increase as prices fall, but in many European countries, particularly Germany, France and Spain, the issue lies with obesity being regarded as a lifestyle disease, and so something that should not be treated with drugs
dual agonists (such as tirzepatide) target two (GLP-1 and gastric inhibitory polypeptide, or GIP)
Shipping four single-dose pens versus one multi-dose device changes the unit economics of packaging, fulfillment, and supply chain complexity, especially when demand is strong and shortages can quickly become headline risk
Severe diarrhea with weakness also needs prompt assessment
Bariatric Surgery For many struggling with obesity, achieving and maintaining a healthy weight can feel like an uphill battle